InPsytech, Inc. (TPEX:7898)
Taiwan · Delayed Price · Currency is TWD 376.00
+7.50 (2.04%)
At close: Sep 4, 2026
InPsytech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 681.47 | 469.28 | 326.45 |
Short-Term Investments | - | - | 184.23 |
Cash & Short-Term Investments | 681.47 | 469.28 | 510.68 |
Cash Growth | 45.21% | -8.11% | - |
Accounts Receivable | 123.25 | 12.48 | 31.24 |
Other Receivables | 17.2 | 26.83 | 13.04 |
Receivables | 140.46 | 159.95 | 44.28 |
Prepaid Expenses | 94.69 | 2.01 | 1.13 |
Other Current Assets | 17.59 | 3.25 | 14.74 |
Total Current Assets | 934.2 | 634.49 | 570.83 |
Property, Plant & Equipment | 8.69 | 6.95 | 8.32 |
Long-Term Investments | 62.5 | - | - |
Other Intangible Assets | 1.6 | - | 0.19 |
Long-Term Deferred Tax Assets | - | - | 4.52 |
Other Long-Term Assets | 2.18 | 0.17 | 7.65 |
Total Assets | 1,009 | 641.61 | 591.5 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accrued Expenses | 52.72 | 30.87 | 21.97 |
Current Portion of Leases | - | - | 3.67 |
Current Income Taxes Payable | - | 29.07 | - |
Current Unearned Revenue | 40.82 | 157.31 | 168.82 |
Other Current Liabilities | 15.82 | 15.8 | 10.95 |
Total Current Liabilities | 109.36 | 233.04 | 205.41 |
Long-Term Leases | - | - | 2.76 |
Long-Term Unearned Revenue | - | - | 15.59 |
Long-Term Deferred Tax Liabilities | 2.1 | 4.94 | 1.7 |
Total Liabilities | 111.46 | 237.98 | 225.47 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 300.39 | 44.65 | 147.09 |
Additional Paid-In Capital | 405.64 | 128.44 | 226 |
Retained Earnings | 191.68 | 230.54 | -7.05 |
Shareholders' Equity | 897.71 | 403.63 | 366.04 |
Total Liabilities & Equity | 1,009 | 641.61 | 591.5 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | - | - | 6.43 |
Net Cash (Debt) | 681.47 | 469.28 | 504.25 |
Net Cash Growth | 45.21% | -6.93% | - |
Net Cash Per Share | 23.48 | 37.10 | 37.34 |
Filing Date Shares Outstanding | 30.04 | 4.47 | 13.5 |
Total Common Shares Outstanding | 30.04 | 4.47 | 13.5 |
Working Capital | 824.85 | 401.45 | 365.42 |
Book Value Per Share | 29.89 | 90.40 | 27.11 |
Tangible Book Value | 896.11 | 403.63 | 365.85 |
Tangible Book Value Per Share | 29.83 | 90.40 | 27.09 |
Machinery | 18.12 | 16.21 | 9.9 |